MAPK1 and RASopathy: More recently, we identified activating mutations in the gene encoding the key effector of the MAPK signaling cascade, MAPK1 [OMIM: 176948], as cause of a neurodevelopmental disease within the RASopathies spectrum (Motta et al., 2020).